TY - JOUR
T1 - Characteristics of Decedents With COVID-19–Related Mortality in Kentucky, July 1–August 13, 2021
AU - Cavanaugh, Alyson M.
AU - Raparti, Likhita
AU - Bhurgri, Mishaal
AU - Herrington, Amy
AU - Holladay, Claire
AU - Arora, Vaneet
AU - Spicer, Kevin B.
AU - Thoroughman, Douglas A.
AU - Winter, Kathleen
N1 - Publisher Copyright:
© 2023, Association of Schools and Programs of Public Health.
PY - 2023/5/1
Y1 - 2023/5/1
N2 - Objective: Although vaccination reduces the risk of severe COVID-19, fatal COVID-19 cases after vaccination can occur. We examined the characteristics of decedents with COVID-19–related mortality to help inform discussions about vaccination, boosters, and mitigation strategies. Methods: We examined COVID-19–related deaths in Kentucky resulting from infections occurring from July 1 through August 13, 2021. We used records from case investigations, medical records, the Kentucky Health Information Exchange, and the Kentucky Immunization Registry to determine demographic information, vaccination status, and underlying health conditions, including calculation of the Charlson Comorbidity Index (CCI). We calculated mortality incidence rates by vaccination status by using data for unvaccinated and fully vaccinated populations in Kentucky as of July 1, 2021. Results: In total, 777 COVID-19–related deaths occurred in Kentucky during the study period; 592 (76.2%) occurred among unvaccinated people. Compared with unvaccinated decedents, fully vaccinated decedents were older (median age, 77 vs 65 years; P <.001), had higher comorbidity levels (median CCI, 3 vs 1; P <.001), and were more likely to have immunocompromised health status (26.4% vs 16.0%; P =.003). Diabetes, hypertension, heart disease, and chronic lung disease were more common among vaccinated decedents than among unvaccinated decedents. Unvaccinated adults had a significantly higher risk of death than fully vaccinated adults (incidence rate ratio for age 20-49 years: 20.5 [95% CI, 6.5-64.8]; 50-64 years: 14.6 [95% CI, 9.4-22.7]; ≥65 years: 10.2 [95% CI, 8.3-12.4]). Conclusions: Immunocompromised health status, older age, and higher comorbidity were prevalent among fully vaccinated decedents, suggesting adults with these characteristics may benefit from additional protection strategies. Further understanding of the protection of additional and booster doses is needed.
AB - Objective: Although vaccination reduces the risk of severe COVID-19, fatal COVID-19 cases after vaccination can occur. We examined the characteristics of decedents with COVID-19–related mortality to help inform discussions about vaccination, boosters, and mitigation strategies. Methods: We examined COVID-19–related deaths in Kentucky resulting from infections occurring from July 1 through August 13, 2021. We used records from case investigations, medical records, the Kentucky Health Information Exchange, and the Kentucky Immunization Registry to determine demographic information, vaccination status, and underlying health conditions, including calculation of the Charlson Comorbidity Index (CCI). We calculated mortality incidence rates by vaccination status by using data for unvaccinated and fully vaccinated populations in Kentucky as of July 1, 2021. Results: In total, 777 COVID-19–related deaths occurred in Kentucky during the study period; 592 (76.2%) occurred among unvaccinated people. Compared with unvaccinated decedents, fully vaccinated decedents were older (median age, 77 vs 65 years; P <.001), had higher comorbidity levels (median CCI, 3 vs 1; P <.001), and were more likely to have immunocompromised health status (26.4% vs 16.0%; P =.003). Diabetes, hypertension, heart disease, and chronic lung disease were more common among vaccinated decedents than among unvaccinated decedents. Unvaccinated adults had a significantly higher risk of death than fully vaccinated adults (incidence rate ratio for age 20-49 years: 20.5 [95% CI, 6.5-64.8]; 50-64 years: 14.6 [95% CI, 9.4-22.7]; ≥65 years: 10.2 [95% CI, 8.3-12.4]). Conclusions: Immunocompromised health status, older age, and higher comorbidity were prevalent among fully vaccinated decedents, suggesting adults with these characteristics may benefit from additional protection strategies. Further understanding of the protection of additional and booster doses is needed.
KW - COVID-19
KW - Delta variant
KW - mortality
KW - underlying conditions
KW - vaccines
UR - http://www.scopus.com/inward/record.url?scp=85150942304&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150942304&partnerID=8YFLogxK
U2 - 10.1177/00333549231155867
DO - 10.1177/00333549231155867
M3 - Article
C2 - 36927290
AN - SCOPUS:85150942304
SN - 0033-3549
VL - 138
SP - 526
EP - 534
JO - Public Health Reports
JF - Public Health Reports
IS - 3
ER -